Canaccord raised the firm’s price target on Cipher Pharmaceuticals (CPHRF) to C$13 from C$12.50 and keeps a Hold rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPHRF:
- Cipher Pharmaceuticals Reports Strong Revenue Growth in Q1 2025
- Cipher Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
- Cipher Pharmaceuticals Reports Strong Q1 2025 Results and Strategic Debt Repayment
- CPHRF Upcoming Earnings Report: What to Expect?
- Cipher Pharmaceuticals to Announce Q1 2025 Financial Results
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue